These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11981351)
1. The adequacy of pharmacotherapy in outpatients with obsessive-compulsive disorder. Denys D; Van Megen H; Westenberg H Int Clin Psychopharmacol; 2002 May; 17(3):109-14. PubMed ID: 11981351 [TBL] [Abstract][Full Text] [Related]
2. Outpatient Treatment Patterns of Pediatric Obsessive-Compulsive Disorder. Smith JL; McBride NM; Storch EA J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):509-515. PubMed ID: 28375695 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoepidemiology of obsessive-compulsive disorder: A Swedish nationwide cohort study. Isomura K; Nordsletten AE; Rück C; Ljung R; Ivarsson T; Larsson H; Mataix-Cols D Eur Neuropsychopharmacol; 2016 Apr; 26(4):693-704. PubMed ID: 26922101 [TBL] [Abstract][Full Text] [Related]
4. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912 [TBL] [Abstract][Full Text] [Related]
5. Treatment of obsessive-compulsive disorder by U.S. psychiatrists. Blanco C; Olfson M; Stein DJ; Simpson HB; Gameroff MJ; Narrow WH J Clin Psychiatry; 2006 Jun; 67(6):946-51. PubMed ID: 16848654 [TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422 [TBL] [Abstract][Full Text] [Related]